QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin

PURPOSE: Hydroxychloroquine, chloroquine, and azithromycin have been used for treatment of COVID-19, but may cause QT prolongation. Minority populations are disproportionately impacted by COVID-19. This study evaluates the risk of QT prolongation and subsequent outcomes after administration of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsia, Brian C, Greige, Nicolas, Quiroz, Jose A, Khokhar, Ahmed S, Daily, Johanna, Di Biase, Luigi, Ferrick, Kevin J, Fisher, John D, Krumerman, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352082/
https://www.ncbi.nlm.nih.gov/pubmed/32654098
http://dx.doi.org/10.1007/s10840-020-00822-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352082/
https://www.ncbi.nlm.nih.gov/pubmed/32654098
http://dx.doi.org/10.1007/s10840-020-00822-x

Ejemplares similares